Aura Lifecare Profile
Key Indicators
- Authorised Capital ₹ 5.05 Cr
as on 18-07-2024
- Paid Up Capital ₹ 5.00 Cr
as on 18-07-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 57.79 Cr
as on 18-07-2024
- Revenue 13.29%
(FY 2023)
- Profit 189.92%
(FY 2023)
- Ebitda 8241.81%
(FY 2023)
- Net Worth 45.47%
(FY 2023)
- Total Assets 6.01%
(FY 2023)
About Aura Lifecare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.05 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹57.79 Cr.
Santosh Dsouza, Sultanali Mulani, and Pawankumar Mittal serve as directors at the Company.
- CIN/LLPIN
U24230GJ2012PTC070929
- Company No.
070929
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Savli, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aura Lifecare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawankumar Mittal  | Director | 01-Jan-2018 | Current |
| Santosh Dsouza | Director | 27-Jun-2012 | Current |
| Sultanali Mulani | Director | 27-Jun-2012 | Current |
Financial Performance and Corporate Structure Insights of Aura Lifecare.
Aura Lifecare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.29% increase. The company also saw a substantial improvement in profitability, with a 189.92% increase in profit. The company's net worth Soared by an impressive increase of 45.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aura Lifecare?
In 2023, Aura Lifecare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aura Pharmaceuticals Private LimitedActive 15 years 3 daysSantosh Dsouza and Sultanali Mulani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Mar 2024 | ₹5.05 Cr | Open |
Hdfc Bank Limited Creation Date: 23 Mar 2023 | ₹17.00 Cr | Open |
Hdfc Bank Limited Creation Date: 22 Feb 2023 | ₹6.24 M | Open |
How Many Employees Work at Aura Lifecare?
Aura Lifecare has a workforce of 188 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aura Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aura Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
